Health TrialsbyHealthPanel

Therapeutic Efficacy of Different Wavelengths of Low-Level Laser Therapy in the Treatment of Cervicogenic Headache

ConditionCervicogenic Headache
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorUniversity of Lahore

About this trial

This study tests if low-level laser therapy (LLLT) with different light wavelengths can help people with cervicogenic headache, a type of headache caused by neck problems. Adults aged 18-65 with this headache for at least 3 months will try one of three LLLT treatments (675nm, 820nm, or a mix of wavelengths) along with regular physical therapy like stretching and exercises. The study will check pain levels, how often headaches happen, neck movement, disability, and quality of life over 6 weeks, with follow-ups at 3 and 6 months. the investigators want to find the best LLLT option to reduce headache symptoms safely.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients aged 18-65 years diagnosed with cervicogenic headache based on the International Classification of Headache Disorders (ICHD-3) criteria.

Persistent headaches for at least 3 months.

No previous exposure to low-level laser therapy (LLLT).

Disqualifiers

Patients with other primary headache disorders (e.g., migraine, tension-type headache).

History of cervical spine surgery.

Pregnant or lactating women.

Patients with a history of photosensitivity or taking photosensitizing medications.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Low-Level Laser Therapy (LLLT)

    Device

    Low-level laser therapy using the Omega XP Model with wavelengths of 675nm (30mW), 820nm (200mW), or 46-cluster LED probe (mixed wavelengths: 660nm, 950nm, 870nm, 880nm, 940nm, 820nm), applied three times weekly for 30 minutes over 6 weeks to target cervical lymphatic chain, musculature, and trigger points for pain relief in cervicogenic headache.

  • Routine Physical Therapy (RPT)

    Other intervention

    Warm-up: Active cervical ROM (5-10 reps, pain-free range). Stretching: Upper trapezius, levator scapulae, SCM; hold 15-30 sec, 3-5 reps, NRS ≤ 3/10. Therapeutic exercises: cervical deep flexors, scapular stabilization (2-3 sets × 10-15 reps, Borg 11-13), progressed weekly. Modalities: Hot pack 15 min at 40-45°C; TENS 80-100 Hz, 50-100 µs pulse width, 20 min. Frequency: 3× weekly for 6 weeks. Safety: contraindications screened; pain/exertion monitored pre/post.

Treatment groups

150 Participants
are divided into 3 treatment groups
Group A: Group 1: 675nm LLLT + RPTExperimental treatment 2 interventions
Group B: Group 2: 820nm LLLT + RPTExperimental treatment 2 interventions
Group C: Group 3: 46 Cluster LED Probe + RPTExperimental treatment 2 interventions

Trial outcomes

Primary outcomes

1

Number of Participants with Reduction in Headache Frequency

Measured by patient diary recording

Time frame
Baseline, 3 weeks, 6 weeks, 3 months, 6 months
2

Mean Change in Pain Intensity (VAS Score, 0-10)

Measured by Visual Analog Scale (VAS, 0-10)

Time frame
Baseline, 3 weeks, 6 weeks, 3 months, 6 months

Secondary outcomes

1

Change in Cervical ROM (degrees)

Measured by universal goniometer

Time frame
Baseline, 3 weeks, 6 weeks, 3 months, 6 months
2

Mean Difference in Neck Disability Index (NDI) Score

Measured by Neck Disability Index (NDI, Urdu version)

Time frame
Baseline, 3 weeks, 6 weeks, 3 months, 6 months
3

Mean Change in SF-36 Quality of Life Score

Measured by Short Form Health Survey (SF-36)

Time frame
Baseline, 3 weeks, 6 weeks, 3 months, 6 months
4

Change in Forward Head Posture (degrees, camera-based measurement)

Measured by mobile camera picture, degree

Time frame
Baseline, 3 weeks, 6 weeks, 3 months, 6 months

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of Lahore

Lead sponsor

Source ClinicalTrials.gov
Apply now